ArticleTheranostics2023

Blockade of dual immune checkpoint inhibitory signals with a CD47/PD-L1 bispecific antibody for cancer treatment.

Rongjuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.